Search Results

You are looking at 111 - 120 of 793 items for :

  • "screening" x
Clear All
Full access

Alice T. Shaw, Benjamin Solomon and Mari Mino Kenudson

. How current methods for detecting ALK could impact screening algorithms for NSCLC patients is also discussed. ALK FISH: The Current Gold Standard The break apart FISH assay for detecting ALK rearrangements has served as the standard test for

Full access

Crystal S. Denlinger, Jennifer A. Ligibel, Madhuri Are, K. Scott Baker, Wendy Demark-Wahnefried, Debra L. Friedman, Mindy Goldman, Lee Jones, Allison King, Grace H. Ku, Elizabeth Kvale, Terry S. Langbaum, Kristin Leonardi-Warren, Mary S. McCabe, Michelle Melisko, Jose G. Montoya, Kathi Mooney, Mary Ann Morgan, Javid J. Moslehi, Tracey O’Connor, Linda Overholser, Electra D. Paskett, Muhammad Raza, Karen L. Syrjala, Susan G. Urba, Mark T. Wakabayashi, Phyllis Zee, Nicole McMillian and Deborah Freedman-Cass

shooting. Neuropathic pain often occurs as a side effect of chemotherapy or radiation therapy or is caused by surgical injury to the nerves. Screening for and Assessment of Pain All cancer survivors should be screened for pain at regular intervals

Full access

Michelle B. Riba, Kristine A. Donovan, Barbara Andersen, IIana Braun, William S. Breitbart, Benjamin W. Brewer, Luke O. Buchmann, Matthew M. Clark, Molly Collins, Cheyenne Corbett, Stewart Fleishman, Sofia Garcia, Donna B. Greenberg, Rev. George F. Handzo, Laura Hoofring, Chao-Hui Huang, Robin Lally, Sara Martin, Lisa McGuffey, William Mitchell, Laura J. Morrison, Megan Pailler, Oxana Palesh, Francine Parnes, Janice P. Pazar, Laurel Ralston, Jaroslava Salman, Moreen M. Shannon-Dudley, Alan D. Valentine, Nicole R. McMillian and Susan D. Darlow

life and may even negatively affect survival. 25 – 28 Furthermore, survivors with untreated distress have poorer compliance with surveillance screenings and are less likely to exercise and quit smoking. 29 Early evaluation and screening for distress

Full access

Rita A. Mukhtar, Jasmine M. Wong and Laura J. Esserman

also reduces morbidity for women who potentially derive little or no benefit from receiving treatments designed for other tumor types. 10 Although tailored treatment has improved outcomes in breast cancer, 10 the implementation of screening programs

Full access

Kaylene Ready and Banu Arun

, proven screening and risk reduction modalities are available. For example, a woman carrying a BRCA1 or BRCA2 mutation can be offered the following risk management options: semiannual breast cancer screening using both mammogram and breast MRI 3

Full access

't treat it, we don't look for it,’” she said. This means that cancer prevention efforts can be largely futile. An individual may be persuaded to undergo a mammogram or colonoscopy, but they often cannot find a location that provides those screenings. Dr

Full access

Patrick M. Lynch

most respects it reflects the position of the NCCN Colorectal Cancer Screening Panel, of which I am a member. However, this article discusses some emerging trends that may yet not be well established. As a formulator of clinical practice guidelines, the

Full access

Crystal S. Denlinger, Jennifer A. Ligibel, Madhuri Are, K. Scott Baker, Wendy Demark-Wahnefried, Debra L. Friedman, Mindy Goldman, Lee Jones, Allison King, Grace H. Ku, Elizabeth Kvale, Terry S. Langbaum, Kristin Leonardi-Warren, Mary S. McCabe, Michelle Melisko, Jose G. Montoya, Kathi Mooney, Mary Ann Morgan, Javid J. Moslehi, Tracey O’Connor, Linda Overholser, Electra D. Paskett, Muhammad Raza, Karen L. Syrjala, Susan G. Urba, Mark T. Wakabayashi, Phyllis Zee, Nicole McMillian and Deborah Freedman-Cass

Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Palliative Care and the NCCN Guidelines for Cancer-Related Fatigue (available at NCCN.org ). These guidelines may be modified to fit the individual survivor’s circumstances. Screening for

Full access

Patrick M. Lynch

Guidelines in Oncology (NCCN Guidelines) for Colorectal Cancer (CRC) Screening address the evaluation and management of patients at risk of inherited susceptibility to colorectal cancer (available in this issue; to view the most recent version of these

Full access

Crystal S. Denlinger, Jennifer A. Ligibel, Madhuri Are, K. Scott Baker, Gregory Broderick, Wendy Demark-Wahnefried, Debra L. Friedman, Mindy Goldman, Lee W. Jones, Allison King, Grace H. Ku, Elizabeth Kvale, Terry S. Langbaum, Mary S. McCabe, Michelle Melisko, Jose G. Montoya, Kathi Mooney, Mary Ann Morgan, Javid J. Moslehi, Tracey O'Connor, Linda Overholser, Electra D. Paskett, Jeffrey Peppercorn, M. Alma Rodriguez, Kathryn J. Ruddy, Tara Sanft, Paula Silverman, Sophia Smith, Karen L. Syrjala, Susan G. Urba, Mark T. Wakabayashi, Phyllis Zee, Nicole R. McMillian and Deborah A. Freedman-Cass

Guidelines in Oncology (NCCN Guidelines) for Survivorship aid health care professionals who work with survivors of adult-onset cancers in the posttreatment period by providing screening, evaluation, and treatment recommendations for common consequences of